FDA Drug Application (074752) for CARTIA XT by ACTAVIS LABS FL INC

Back to FDA Applications sponsored by ACTAVIS LABS FL INC

Application Number074752
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage180MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB3 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCARTIA XT
Active IngredientDILTIAZEM HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient DILTIAZEM HYDROCHLORIDE11


Back to FDA Applications sponsored by ACTAVIS LABS FL INC